Panthura

Panthura is at the forefront of biotechnology research, dedicated to developing the next generation of targeted gene therapies. With a focus on replacing mutated DNA with functional DNA, Panthura aims to treat disease through innovative non-viral nanoparticle delivery systems. The company's primary address is in Oxford, GB, with an additional location at 85 Great Portland Street, London, England W1W 7LT, GB.

Panthura's leading program is focused on pioneering a gene therapy for cystic fibrosis, showcasing their commitment to addressing critical medical needs. Through rigorous research and cutting-edge techniques, Panthura is poised to make significant advancements in the field of gene therapy.

Panthura is committed to innovation and improving patient outcomes. We invite the management team at Panthura to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.